SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-16
👔
ROCKET PHARMACEUTICALS, INC.
@RCKT_InsiderForm 4 Filing: Wilson Martin Sells $256K of $RCKT
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
ROCKET PHARMACEUTICALS, INC.
Ticker: $RCKT
Transaction Value
$256K
Price/Share: $3.40
transaction date
2026-09-11
Shares: 75,364
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Wilson Martin, holds the title of General Counsel at ROCKET PHARMACEUTICALS, INC..
On 2026-09-11, the insider transacted 75,364 shares.The shares were transacted at a weighted average price of $3.40 per share, resulting in a total market-relevant value of $256K.
Executive Summary Summary
Wilson Martin (General Counsel) sold $256K of $RCKT
Post-Transaction Position: 598,489 shares
SEC Accession No: 0001140361-26-036688 (CIK: 1704342)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.